New Key Statistics Module, Z-Score and F-Score
FRA:CYTH Key Ratios
| Market Cap € M | 6,994.75 |
| Enterprise Value € M | 22,986.84 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 16.30 |
| Price/Sales | 0.54 |
| Price/Free Cash Flow | 49.87 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 12,699.00 |
| EPS (TTM) € | -1.93 |
| Beneish M-Score | -3.26 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -27.26 |
| EV-to-EBITDA | 12.02 |
| PEG | -- |
| Shares Outstanding M | 1,016.81 |
| Net Margin (%) | -15.06 |
| Operating Margin % | 3.06 |
| Pre-tax Margin (%) | -15.79 |
| Quick Ratio | 0.96 |
| Current Ratio | 1.01 |
| ROA % (ttm) | -6.00 |
| ROE % (ttm) | -175.30 |
| ROIC % (ttm) | 1.26 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.29 |
FRA:CYTH Number of Guru Trades
FRA:CYTH Volume of Guru Trades
Gurus Latest Trades with FRA:CYTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:CYTH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers